Article info
Letters
Efficacy of intra-articular bevacizumab for relapsing diffuse-type giant cell tumour
- Correspondence to Dr Michael J Nissen, Division of Rheumatology, Geneva University Hospital, 26 Avenue Beau Sejour, Geneva 1211, Switzerland; michael.j.nissen{at}hcuge.ch
Citation
Efficacy of intra-articular bevacizumab for relapsing diffuse-type giant cell tumour
Publication history
- Received September 10, 2013
- Revised November 28, 2013
- Accepted December 15, 2013
- First published January 8, 2014.
Online issue publication
April 13, 2016
Article Versions
- Previous version (13 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions